In the most recent trading session, Synopsys (SNPS) closed at $501.06, indicating a +1.49% shift from the previous trading day.

According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' ...

Electronic design automation firm Synopsys (SNPS) said it is pleased the U.K.'s antitrust agency has provisionally accepted ...

Ansys (ANSS) and Synopsys (SNPS) on Monday announced that Ansys has entered into an agreement for the sale of its PowerArtist ...

Synopsys Inc. closed $127.38 short of its 52-week high ($629.38), which the company reached on February 22nd.

Synopsys (SNPS) issued the following statement in response to the UK Competition and Markets Authority provisionally accepting its proposed ...

Colorectal cancer (CRC) is a global health concern, and despite advances in radiotherapy, endogenous radioresistance in CRC ...

The stock's fall snapped a two-day winning streak.

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Synopsys (SNPS) said the company is very pleased that the CMA has taken the important step of provisionally accepting proposed ...

A month has gone by since the last earnings report for Synopsys (SNPS). Shares have lost about 6.3% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...